A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

NCT03427710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: CiVi007
OTHER: Placebo

Sponsor

Civi Biopharma, Inc.